Solid Biosciences Inc. (SLDB) Return on equity 2018–2022
Solid Biosciences Inc. (SLDB) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-40.6%FY2022 · since FY2018: -59.8% → -40.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -40.6% | -6.0 pp |
| FY2021 | -34.7% | +32.2 pp |
| FY2020 | -66.8% | +79.6 pp |
| FY2019 | -146.4% | -86.7 pp |
| FY2018 | -59.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice